At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7 enrolled
Drug / intervention
Pars plana vitrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Macular Hole After Diabetic Vitrectomy
In Brief
An observational study evaluating Pars plana vitrectomy for Proliferative Diabetic Retinopathy and Macular Holes. Completed, enrolled 7 participants across 1 site.
Detailed Summary
To present the clinical characteristics and rational treatment of macular hole (MH) after the diabetic vitrectomy (DV) in patients with proliferative diabetic retinopathy (PDR).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProliferative Diabetic Retinopathy, Macular Holes
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartNov 2017
Primary CompletionDec 2017
First PostedMay 2018
TodayJul 2026
First PostedMay 16, 2018
Enrollment StartNov 1, 2017
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 8.1 years ago
Interventions
Pars plana vitrectomyprocedure
Pars plana vitrectomy combined with Internal limiting membrane peeling, inverted internal limiting membrane flap insertion into the macular hole, or lens anterior or posterior capsular flap insertion into the macular hole